Two Sigma Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,052
Closed -$767K 1686
2025
Q4
$767K Sell
8,052
-4,616
-36% -$465K 0.11% 248
2025
Q3
$1.25M Buy
+12,668
New +$1.35M 0.18% 121
2024
Q4
Sell
-51,725
Closed -$6.14M 1795
2024
Q3
$6.14M Buy
51,725
+48,163
+1,352% +$4.43M 0.1% 237
2024
Q2
$286K Buy
+3,562
New +$326K ﹤0.01% 2035
2024
Q1
Sell
-2,792
Closed -$268K 2999
2023
Q4
$295K Buy
2,792
+827
+42% +$83.3K ﹤0.01% 2020
2023
Q3
$213K Sell
1,965
-3,464
-64% -$383K ﹤0.01% 2271
2023
Q2
$586K Sell
5,429
-4,217
-44% -$474K 0.01% 1327
2023
Q1
$1.2M Buy
+9,646
New +$1.32M 0.02% 745
2022
Q4
Sell
-4,672
Closed -$630K 2614
2022
Q3
$630K Buy
+4,672
New +$714K 0.02% 915
2022
Q2
Sell
-4,547
Closed -$695K 2232
2022
Q1
$776K Buy
4,547
+2,741
+152% +$461K 0.03% 738
2021
Q4
$466K Buy
+1,806
New +$495K 0.02% 563
2021
Q1
Sell
-4,012
Closed -$327K 921
2020
Q4
$327K Buy
+4,012
New +$394K 0.01% 974

Other funds holding BNTX

Two Sigma Securities's BNTX Position: Q1 2026 in Review

Two Sigma Securities sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 8,052 shares — an estimated $767K sold.

Two Sigma Securities first reported a position in BNTX in Q4 2020 and held it in 12 quarters. The position peaked at $6.14M in Q3 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Two Sigma Securities reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 8,052 BioNTech shares in Q1 2026, an estimated $767K.
  • Two Sigma Securities first reported a position in BioNTech in Q4 2020 and held it in 12 quarters.
  • Two Sigma Securities's BioNTech position peaked at $6.14M in Q3 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.